论文部分内容阅读
目的探讨阿托伐他汀辅治冠心病对动脉粥样硬化程度的影响。方法选取老年冠心病患者78例,随机分为观察组与对照组各39例。对照组予常规治疗,观察组在常规治疗基础上加用阿托伐他汀治疗,观察比较2组动脉粥样硬化程度改善情况。结果 2组治疗前动脉粥样硬化程度比较差异无统计学意义(P>0.05);治疗后观察组动脉粥样硬化程度明显优于对照组(P<0.01)。结论阿托伐他汀辅治冠心病对改善患者动脉粥样硬化程度具有积极意义,可有效降低患者动脉粥样硬化程度,值得临床推广应用。
Objective To investigate the effect of atorvastatin on coronary atherosclerosis. Methods 78 elderly patients with coronary heart disease were selected and randomly divided into observation group and control group, 39 cases each. The control group was given conventional treatment. The observation group was given atorvastatin on the basis of conventional treatment. The improvement of atherosclerosis in the two groups was observed and compared. Results There was no significant difference in atherosclerosis between the two groups before treatment (P> 0.05). After treatment, the degree of atherosclerosis in the observation group was significantly better than that in the control group (P <0.01). Conclusion Atorvastatin adjuvant coronary heart disease has a positive effect on improving the degree of atherosclerosis in patients, which can effectively reduce the degree of atherosclerosis in patients and is worthy of clinical application.